Dermatology

This site is intended for healthcare professionals only

Login Register

MD Brand Connect
Webinars
Vaccine Hub
MDTV
Fact Check
Health Dialogues

Medical News & Guidelines
Health news
Fact Check
AYUSH
State News
Medical Education
Industry
MDTV

This site is intended for healthcare professionals only

Login Register

LoginRegister

Home
Medical news & Guidelines
Health news
Fact Check
AYUSH
State News
Medical Education
Industry

Ruchika Sharma

Ruchika Sharma joined Medical Dialogue as an Correspondent for the Business Section in 2019. She covers all the updates in the Pharmaceutical field, Policy, Insurance, Business Healthcare, Medical News, Health News, Pharma News, Healthcare and Investment. She has completed her B.Com from Delhi University and then pursued postgraduation in M.Com. She can be contacted at [email protected] Contact no. 011-43720751

Home

Ruchika Sharma

Articles By : Ruchika Sharma

Aurobindo Arm CuraTeQ Partners STADA Arzneimittel AG to Commercialise Biosimilars in Europe

USFDA classifies Aurobindo Pharma arm Bhiwadi facility as OAI

Written By Ruchika Sharma6 Aug 2024 12:30 PM IST

Hyderabad: Aurobindo Pharma has announced that the United States Food and Drug Administration (US FDA) has determined the inspection...

Biocon Biologics Secures BB+ Rating Upgrade from S&P on Improved Financial Metrics

Biocon gets USFDA EIR for Visakhapatnam API facility

Written By Ruchika Sharma6 Aug 2024 11:33 AM IST

Bangalore: Biocon has announced that the Company has received an Establishment Inspection Report (EIR) with Voluntary Action Indicated...

Lupin Receives USFDA EIR with VAI Status for Goa Manufacturing Plant

Lupin bags USFDA nod for Prednisolone Acetate Ophthalmic Suspension

Written By Ruchika Sharma5 Aug 2024 4:31 PM IST

Mumbai: Global pharma major Lupin Limited today announced that it has received approval from the United States Food and Drug Administration (U.S....

Johnson and Johnson Agrees to Cut US Drug Prices in Deal with Trump Administration to Avoid Tariffs

EMA Committee recommends Rybrevant in combo with chemotherapy for adult patients with lung cancer after failure of prior therapy

Written By Ruchika Sharma4 Aug 2024 11:00 AM IST

Beerse: Janssen-Cilag International NV, a Johnson & Johnson company, has announced that the Committee for Medicinal Products for Human Use...

Granules India packaging facility in US successfully completes USFDA inspection

Gland Pharma gets 3 USFDA observations for Pashamylaram facility

Written By Ruchika Sharma3 Aug 2024 4:18 PM IST

Hyderabad: Gland Pharma has announced that the United States Food and Drug Administration (US FDA) has concluded an inspection of the...

CDSCO along with State Drugs Controllers conducted risk-based inspections of 400 premises including MSMEs: JP Nadda

Written By Ruchika Sharma3 Aug 2024 2:00 PM IST

New Delhi: In order to assess the regulatory compliance of drug manufacturing premises in the country, the Central Drugs Standard Control Organization...

Marksans Pharma Gets USFDA Nod for Generic Tessalon Capsules

Marksans Pharma arm gets UK MHRA marketing authorization for oral emergency contraceptive pill

Written By Ruchika Sharma2 Aug 2024 1:30 PM IST

Mumbai: Marksans Pharma Limited has announced that its wholly owned subsidiary Relonchem Limited has received Marketing Authorization for the...

USFDA nod to Caplin Steriles Linezolid Injection to treat serious bacterial infections

Alembic Pharma bags USFDA final nod for cancer injection Nelarabine

Written By Ruchika Sharma2 Aug 2024 12:30 PM IST

Vadodara: Alembic Pharmaceuticals Limited today announced that the Company has received final approval from the US Food & Drug...

JnJ gets USFDA nod for Darzalex Faspro-based quadruplet regimen for newly diagnosed multiple myeloma who are transplant-eligible

Written By Ruchika Sharma2 Aug 2024 11:30 AM IST

Horsham: Johnson & Johnson has announced that the U.S. Food and Drug Administration (FDA) has approved DARZALEX FASPRO (daratumumab and...

NPPA Finally Allows GSK to Discontinue Grisovin FP

US FDA expands Jemperli plus chemotherapy approval to all adult patients with primary advanced or recurrent endometrial cancer: GSK

Written By Ruchika Sharma2 Aug 2024 10:00 AM IST

London: GSK plc has announced the US Food and Drug Administration (FDA) has approved Jemperli (dostarlimab) in combination with carboplatin and...

Sanofis Sarclisa Gets EMA Nod for Subcutaneous On-Body Injector Version

Sanofi gets CDSCO marketing nod for RSV treatment Beyfortus in India

Written By Ruchika Sharma1 Aug 2024 5:30 PM IST

Drugmaker, Sanofi India, has received marketing authorisation approval from the Central Drugs Standard Control Organisation (CDSCO) for Beyfortus in...

Shilpa Medicare bags initial authorization for Rotigotine Transdermal Patch from Europe

Shilpa Pharma Lifesciences receives certificate of suitability from EDQM for Ursodeoxycholic Acid

Written By Ruchika Sharma1 Aug 2024 2:26 PM IST

Karnataka: Shilpa Medicare Limited's 100 percent subsidiary, Shilpa Pharma Lifesciences Limited has received certificate of suitability (CEP)...

Powered By: Hocalwire

X

We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok